Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Varga Viktória Evelin

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2014-2023

2023

Szentimrei, R., Lőrincz, H., Szentpéteri, A., Varga, V. E., Seres, I., Varga, É., Nemes, B. Á., Harangi, M., Paragh, G.: Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation.
Chem.-Biol. Interact. 385 (1), 1-8, (article identifier: 110749), 2023.

doi DEA Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Toxicology

2022

Juhász, I., Ujfalusi, S., Seres, I., Lőrincz, H., Varga, V. E., Paragh, G. J., Somodi, S., Harangi, M., Paragh, G.: Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.
Biomolecules. 12 (1), 1-11, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q2 Molecular Biology

Szentimrei, R., Lőrincz, H., Szentpéteri, A., Varga, V. E., Harangi, M., Seres, I., P. Szabó, R., Nemes, B. Á., Paragh, G.: Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease.
Ren. Fail. 44 (1), 1649-1659, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Critical Care and Intensive Care Medicine

Q2 Medicine (miscellaneous)

Q2 Nephrology

2019

Juhász, I., Ujfalusi, S., Lőrincz, H., Varga, V. E., Somodi, S., Harangi, M., Seres, I., Paragh, G.: Circulating Afamin Level Correlates With Lipoprotein Subpopulations In Non-Diabetic Obese Patients.
Atherosclerosis. 287, e165, (article identifier: 19), 2019.

doi DEA WoS

2018

Varga, V. E., Lőrincz, H., Szentpéteri, A., Juhász, L., Seres, I., Paragh, G. J., Balla, J., Paragh, G., Harangi, M.: Changes in serum afamin and vitamin E levels after selective LDL apheresis.
J. Clin. Apheresis. 33 (5), 569-575, 2018.

doi DEA

Journal metrics:

Q2 Hematology

Q1 Medicine (miscellaneous)

Szentpéteri, A., Lőrincz, H., Somodi, S., Varga, V. E., Paragh, G. J., Seres, I., Paragh, G., Harangi, M.: Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.
Lipids Health Dis. 17 (1), 1-27, 2018.

doi DEA

Journal metrics:

Q2 Biochemistry (medical)

Q2 Clinical Biochemistry

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

2017

Zádori, D., Szpisjak, L., Madar, L., Varga, V. E., Csányi, B., Bencsik, K., Balogh, I., Harangi, M., Kereszty, É., Vécsei, L., Klivényi, P.: Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.
Neurol. Sci. 38 (3), 481-483, 2017.

doi DEA

Journal metrics:

Q2 Dermatology

Q2 Medicine (miscellaneous)

Q2 Neurology (clinical)

Q2 Psychiatry and Mental Health

Szentpéteri, A., Zsíros, N., Varga, V. E., Lőrincz, H., Katkó, M., Seres, I., Fülöp, P., Paragh, G., Harangi, M.: Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.
VASA-J. Vasc. Dis. 46 (5), 370-376, 2017.

doi DEA

Journal metrics:

Q3 Cardiology and Cardiovascular Medicine

Szilasi, M. E., Pák, K., Kardos, L., Varga, V. E., Seres, I., Mikáczó, A., Fodor, A., Szilasi, M., Tajti, G., Papp, C., Gesztelyi, R., Zsuga, J.: The alteration of irisin - brain-derived neurotrophic factor axis parallels severity of distress disorder in bronchial asthma patients.
Front. Neurosci. 11, 1-12, 2017.

doi DEA

Journal metrics:

Q1 Neuroscience (miscellaneous)

2016

10.

Szentimrei, R., Harangi, M., Lőrincz, H., Varga, V. E., Szentpéteri, A., Fülöp, P., Seres, I., Paragh, G.: Altered inflammatory parameters and chemerin levels after renal transplantation.
Atherosclerosis. 252, e224, 2016.

doi DEA WoS

11.

Szentpéteri, A., Lőrincz, H., Zsíros, N., Varga, V. E., Seres, I., Katkó, M., Fülöp, P., Paragh, G., Harangi, M.: Associations between lipid subfractions and serum myeloperoxidase levels in untreated hyperlipidemic patients.
Atherosclerosis. 252, e108, 2016.

doi DEA WoS

12.

Berta, E., Harangi, M., Varga, V. E., Lórincz, H., Seres, I., Nagy, E. V., Paragh, G., Bodor, M.: Evaluation of serum chemerin level in patients with Hashimoto's thyroiditis.
Atherosclerosis. 252, e168, 2016.

doi DEA WoS

13.

Varga, V. E., Lőrincz, H., Zsíros, N., Fülöp, P., Seres, I., Paragh, G., Balla, J., Harangi, M.: Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.
Lipids Health Dis. 15 (182), 1-7, 2016.

doi DEA

Journal metrics:

Q1 Biochemistry (medical)

Q2 Clinical Biochemistry

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

14.

Zsíros, N., Koncsos, P., Lőrincz, H., Seres, I., Katkó, M., Szentpéteri, A., Varga, V. E., Fülöp, P., Paragh, G., Harangi, M.: Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Clin. Biochem. 49 (12), 862-867, 2016.

doi DEA

Journal metrics:

Q2 Clinical Biochemistry

Q1 Medicine (miscellaneous)

2015

15.

Varga, V. E., Katkó, M., Harangi, J., Seres, I., Paragh, G., Harangi, M.: Importance of serum cholestanol measurement by gas chromatography-mass spectrometry in a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis.
Atherosclerosis. 241 (1), e117, 2015.

DEA

16.

Paragh, G., Zsíros, N., Varga, V. E., Szentpéteri, A., Lőrincz, H., Katkó, M., Seres, I., Fülöp, P., Harangi, M.: Myeloperoxidase and human paraoxonase-1 correlates with vascular biomarkers in untreated hyperlipidemic patients.
Atherosclerosis. 241 (1), e98, 2015.

DEA

17.

Harangi, M., Varga, V. E., Lőrincz, H., Zsíros, N., Seres, I., Fülöp, P., Balla, J., Paragh, G.: Selective ldl apheresis decreases serum chemerin levels in patients with heterozygous familial hypercholesterolemia.
Atherosclerosis. 241 (1), e637, 2015.

DEA

2014

18.

Varga, V. E., Katkó, M., Harangi, J., Balogh, I., Kapás, I., Madar, L., Seres, I., Molnár, M. J., Paragh, G., Kovács, G. G., Harangi, M.: Egy ritka, veleszületett neurodegeneratív betegség: a cerebrotendinosus xanthomatosis laboratóriumi diagnosztikája.
Orv. Hetil. 155 (21), 811-816, 2014.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)